Description
Product Description
Liraglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1) and is extensively studied in metabolic regulation, receptor signaling, and peptide pharmacology research. Due to its modified molecular structure, Liraglutide exhibits enhanced stability and receptor affinity compared with native GLP-1, making it a valuable reference compound in laboratory investigations.
This product is supplied as a lyophilized powder in sterile glass vials, providing excellent long-term stability, convenient storage, and reliable batch consistency. Liraglutide peptide is manufactured using advanced peptide synthesis and purification technologies, achieving a purity level of 99%, verified by HPLC and mass spectrometry. Each batch is accompanied by a batch-specific Certificate of Analysis (COA) and full analytical documentation.
In research applications, Liraglutide peptide is widely used in studies involving GLP-1 receptor signaling, glucose metabolism pathways, insulin secretion mechanisms, appetite regulation pathways, and peptide–receptor interaction analysis. Its well-characterized pharmacological profile supports use in both in vitro cell-based assays and controlled exploratory preclinical research models.
This Liraglutide peptide product is supplied strictly for research and laboratory use only and is not intended for therapeutic, diagnostic, or veterinary applications.

Product Specifications
| Item | Description |
|---|---|
| Product Name | Liraglutide Peptide |
| Peptide Type | Synthetic GLP-1 analog |
| Form | Lyophilized powder |
| Purity | 99% |
| Strength Options | 5 mg, 10 mg, 20 mg, 30 mg |
| Appearance | White to off-white lyophilized solid |
| Identity Verification | HPLC, Mass Spectrometry |
| Solubility | Soluble in sterile water or suitable buffers |
| Packaging | Sterile glass vials |
| Storage Condition | −20 °C recommended |
| Intended Use | Research use only |
Applications
Liraglutide peptide is widely applied in laboratory and academic research, including:
GLP-1 receptor signaling pathway studies
Glucose metabolism and insulin secretion research
Appetite regulation mechanism investigations
Peptide–receptor binding affinity analysis
Structure–activity relationship (SAR) research
Metabolic disorder research models
Comparative GLP-1 analog studies
Exploratory preclinical research models
Packaging
Sterile sealed glass vials with lyophilized powder
Available vial sizes: 5 mg, 10 mg, 20 mg, 30 mg
Bulk and wholesale packaging supported
Custom labeling options available upon request

Liraglutide peptide lyophilized powder in a vial
Storage & Transportation Conditions
Store at −20 °C in a dry, light-protected environment
Avoid repeated freeze–thaw cycles after reconstitution
Transport under temperature-controlled conditions when required
Protect from moisture and direct sunlight
Inquiry & Technical Consultation
For technical documentation, bulk supply details, or batch-specific analytical data related to Liraglutide peptide, please submit your inquiry using the contact form below.
Our technical team can provide COA, HPLC, MS reports, and research-related assistance.
Payment & Ordering Support
is supplied to research institutions, laboratories, and qualified B2B partners.
International wholesale transactions may support wire transfer and escrow-based B2B trade payment options, subject to agreement.
Disclaimer
Liraglutide Sterile Solution is intended exclusively for laboratory research use and must not be used for human or veterinary applications, clinical treatments, or consumption. Researchers must strictly follow institutional biosafety guidelines and regulatory protocols when handling this peptide. All experimental use should adhere to recommended concentrations, storage, and administration procedures to maintain safety and reproducibility. The product is provided solely as a research reagent and is not evaluated for therapeutic purposes.






Reviews
There are no reviews yet.